copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - Æxlishemjandi lyf - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
lumykras
amgen europe bv - sotorasib - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.
darunavir medical valley filmuhúðuð tafla 600 mg
medical valley invest ab - darunavir propylene glycolate - filmuhúðuð tafla - 600 mg
eliquis (lyfjaver) filmuhúðuð tafla 5 mg
lyfjaver ehf. - apixabanum inn - filmuhúðuð tafla - 5 mg
sporanox hart hylki 100 mg
janssen-cilag ab - itraconazolum inn - hart hylki - 100 mg
darunavir medical valley filmuhúðuð tafla 800 mg
medical valley invest ab - darunavir propylene glycolate - filmuhúðuð tafla - 800 mg
arthrotec tafla 50/0,2 mg
pfizer aps - diclofenacum natríum; misoprostolum inn - tafla - 50/0,2 mg
arthrotec forte tafla 75/0,2 mg
pfizer aps - diclofenacum natríum; misoprostolum inn - tafla - 75/0,2 mg
tambocor tafla 100 mg
viatris aps - flecainidum acetat - tafla - 100 mg